Related Experiment Video
Updated: Jun 11, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative
Background And Purpose:
After acute ischemic stroke, the proportion of patients with detectable lesions on fluid-attenuated inversion recovery (FLAIR) MRI sequences increases over time. We investigated whether thrombolysis was less effective in FLAIR-positive versus -negative patients.
Methods:
In this single-center hospital-based study, all consecutive patients with ischemic stroke who underwent an MRI before and 24 hours after thrombolysis between May 2008 and October 2009 were included. Patients were included if exact time of onset was known and thrombolysis was performed within 3 hours up until August 2008 and within 4.5 hours from September 2008 on. Blinded to time of symptom onset, 3 raters independently judged the visibility of lesions on FLAIR. Lesion volumes on diffusion-weighted imaging as well as National Institutes of Health Stroke Scale before and 1 day after thrombolysis were determined.
Results:
Of 51 patients (25 females, mean age 71, median National Institutes of Health Stroke Scale 6), 26 were FLAIR-positive. Neither lesion growth nor change in National Institutes of Health Stroke Scale differed significantly between FLAIR-positive versus -negative patients: median growth 2.6 mL (interquartile growth, -0.1 to 17.6) versus 0.8 mL (interquartile range, 0.1 to 17.8) and change in National Institutes of Health Stroke Scale -2.5 (interquartile range, -5 to 0) versus -2.0 (interquartile range, -5 to 0.5), respectively (P>0.5, Mann-Whitney rank sum test).
Conclusions:
Visibility of lesions on FLAIR in areas of diffusion restriction was not predictive of the response to thrombolysis.
Insights
Fluid-attenuated inversion recovery (FLAIR) MRI lesion visibility did not predict thrombolysis effectiveness in acute ischemic stroke patients. This finding suggests FLAIR status does not influence treatment outcomes in stroke care.
Area of Science:
- Neurology
- Radiology
- Emergency Medicine
Background:
- Acute ischemic stroke patients often show increasing detectable lesions on FLAIR MRI over time.
- This study investigated if thrombolysis effectiveness differs between FLAIR-positive and FLAIR-negative acute ischemic stroke patients.
Discussion:
- No significant difference in lesion growth or NIH Stroke Scale change was observed between FLAIR-positive and FLAIR-negative groups.
- This suggests that the presence of visible lesions on FLAIR MRI does not impact the response to thrombolysis.
Key Insights:
- FLAIR MRI lesion visibility is not a predictor of thrombolysis response in acute ischemic stroke.
- Thrombolysis outcomes are comparable regardless of whether lesions are visible on FLAIR MRI at the time of treatment.
Outlook:
- Further research could explore other imaging biomarkers to predict thrombolysis response.
- Investigating the role of diffusion-weighted imaging (DWI) in conjunction with FLAIR may offer deeper insights into stroke pathophysiology and treatment efficacy.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
